(Q43509250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author

Christopher J. Weight

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Eric A Klein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Stephen Jones

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

2195-2201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Quality-of-life outcomes in long-term survivors of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Patients' choice of treatment in stage D prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Medical versus surgical androgen suppression therapy for prostate cancer: a 10-year longitudinal cost study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Cost-effectiveness of androgen suppression therapies in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

National practice patterns and time trends in androgen ablation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Pathologic stage migration has slowed in the late PSA era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Intermittent androgen deprivation for locally advanced prostate cancer. Preliminary experience from an ongoing randomized controlled study of the South European urooncological group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

Lack of physician concordance with guidelines on the perioperative use of beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

7 January 2021

Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

7 January 2021

Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

7 January 2021

Androgen deprivation as primary treatment for early prostate cancer: should we "just do something"?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

7 January 2021

Gonadotrophin-releasing hormone agonists induce osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

7 January 2021

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23421

7 January 2021

Identifiers

DOI

10.1002/CNCR.23421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18393326%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference